Akebia Therapeutics Inc. (AKBA)
NASDAQ: AKBA
· Real-Time Price · USD
2.83
0.12 (4.43%)
At close: Oct 03, 2025, 3:59 PM
2.83
-0.03%
After-hours: Oct 03, 2025, 07:56 PM EDT
Akebia Therapeutics Revenue
Akebia Therapeutics reported an annual revenue of $160.18M, reflecting a -17.7% growth. For the quarter ending June 30, 2025, Akebia Therapeutics generated $62.47M in revenue.
Revenue (ttm)
160.18M
Revenue Growth
-17.7%
Price / Sales Ratio
2.5
Revenue / Employee
884.97K
Employees
181
Market Cap
750.36M
Revenue Chart
History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 160.18M | -17.70% |
| Dec 31, 2023 | 194.62M | -33.49% |
| Dec 31, 2022 | 292.6M | +37.00% |
| Dec 31, 2021 | 213.58M | -27.68% |
| Dec 31, 2020 | 295.31M | -11.85% |
| Dec 31, 2019 | 335M | +61.26% |
| Dec 31, 2018 | 207.74M | +16.72% |
| Dec 31, 2017 | 177.98M | +11495.05% |
| Dec 31, 2016 | 1.53M | +Infinity% |
| Dec 31, 2015 | 0 | n/a |
| Dec 31, 2014 | 0 | n/a |
| Dec 31, 2013 | 0 | n/a |
| Dec 31, 2012 | 0 | n/a |